VisEn Medical, Inc. (VisEn), a diagnostic imaging company, has expanded its FMT 2500 quantitative tomography platform to access four channels of quantitative fluorescent imaging. The new channels -- 635 nm, 670 nm, 745 nm, and 790 nm -- are designed to provide greater flexibility in imaging and multiplexing of VisEn's fluorescent imaging agents in multiple disease pathways in vivo.
VisEn has also launched its line of FMT multimodality adapters, which allow researchers to combine FMT readouts with imaging results from microCT, PET, MR, and SPECT platforms.
FMT 2500 Four Channel Imaging Upgrade and System Available Summer 2009
The expanded FMT 2500 Four Channel offering will become available in the summer of 2009 and can be purchased as an upgrade to existing FMT 2500 systems, or as an added feature to a new FMT system. In addition to the standard wavelengths of 670 nm and 745 nm offered in the FMT 2500, VisEn will now offer customers FMT imaging in two new laser wavelengths: 635 nm and 790 nm. Upgrading the FMT 2500 from two to four channels to span a broader spectral fluorescence range from 650 – 850 nm allows researchers greater imaging and fluorescence quantification capability in vivo.
“This expanded range of multi-modality and multi-plexing in vivo imaging products will allow FMT 2500-equipped research and pharmaceutical scientists even greater capabilities in measuring and quantifying biomarkers, disease progression and therapeutic efficacy in vivo,” said Kirtland Poss, president and chief executive officer of VisEn. “We could not be more pleased with how these technologies continue to expand translational research and drug develoment today.”
FMT 2500 Multi-Modality Adaptors Available Now
VisEn’s new line of FMT Multi-Modality imaging adapters enables research scientists to combine imaging approaches and to fuse data sets from both FMT and a second modality including MRI, CT, Spect or PET.